Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 51 - 100 out of 28,400

Document Document Title
WO/2014/135776A1
The invention relates to abexinostate tosylate of formula (II): and the crystalline form I thereof, characterized by the powder diffraction pattern X thereof, the Raman spectrum thereof, and the solid state 13C CP/MAS NMR spectrum thereo...  
WO/2014/135095A1
Provided are compounds of formula (I) and methods of controlling insects, acarines, nematodes or molluscs, which comprises applying to a pest, to a locus of a pest, or to a plant susceptible to attack by a pest an insecticidally, acarici...  
WO/2014/132178A2
The present invention concerns the use of a furfural derivative of formula (I) in which R represents (i) a -CH=CR'1-COR1 group, a group (ii), a group (iii), a group (iv) or a -CHO group and R' represents a hydrogen atom or a (C1-C4)alkyl...  
WO/2014/133361A1
The present invention relates to: a compound selected from the group consisting of a tricyclic compound having the structure of formula I, a pharmaceutically acceptable salt, an isomer, a solvate and a precursor thereof; and a use thereo...  
WO/2014/132975A1
In this method, a diastereomeric mixture containing a (2R)-2-fluoro-2-C-methyl-D-ribono-γ-lactone precursor is deprotected under acidic conditions; subsequently, by lactonizing the same, a diastereomeric mixture of dihydroxylactone is o...  
WO/2014/131825A1
The present invention relates to a multilayer tablet formulation comprising a combination of quetiapine or a pharmaceutically acceptable salt thereof and escitalopram or a pharmaceutically acceptable salt thereof.  
WO/2014/129846A1
The present invention relates to organic electroluminescent compounds of formula 1 (see below) wherein X, A, B, C and R4, R5, R6, R7, a, b, c. d. e, l, m, and n are as defined in the description. The invention also relates to organic ele...  
WO/2014/129874A1
The present invention relates to: a novel α,β-unsaturated amide compound; a method for preparing a composition for preventing or treating obesity, comprising the steps of selecting a compound showing an obesity prevention or treatment ...  
WO/2014/129612A1
The present invention provides a process for producing a compound of the formula (1) wherein X represents a hydrogen atom, etc., and Y represents a hydrogen atom, etc., which comprises step 1 of reacting a compound of the formula (2) and...  
WO/2014/128723A2
The invention disclosed herein relates to novel Peribysin E analogues of general formula-I. Further the invention provides simple, economical and short synthesis of Peribysin E and its analogues of Formula I, in good yield and purity lea...  
WO/2014/125145A1
The invention relates to a novel method for modifying hydroxylated cyclic amino acids, especially 4-hydroxyproline, which is a commercial, relatively cheap, natural amino acid, in order to provide other amino acids of high optical purity...  
WO/2014/124552A1
The present invention relates to N-substituted amino butyrolactone derivatives and uses thereof. In particular, the present invention relates to compounds of formula I or pharmaceutically acceptable salts, solvates, esters, prodrugs, iso...  
WO/2014/125075A1
The present invention relates to a antibiotically active compounds characterized by general formula (I), wherein X1, BB, BC, BD, BE and X2 are building blocks with D1, D2, D3, D4 or D5 being linkers which comprise carbon, sulphur, nitrog...  
WO/2014/126068A1
The present invention provides a catalyst precursor which contains ruthenium that has a first ligand, which is a chiral cyclic diene ligand, and a second ligand.  
WO/2014/122067A1
The present invention relates to compounds of general formula I, (I) wherein the group R1 is defined as in claim 1, which have valuable pharmacological properties, in particular bind to the G-protein coupled receptor 40 (GPR40, also know...  
WO/2014/123203A1
Provided is a compound having PTP-1B inhibitory activity that is excellent as a drug, or a pharmaceutically acceptable salt thereof. A compound represented by general formula (I) (in the formula, each symbol means the same as in the spec...  
WO/2014/121513A1
The present invention concerns a process for the production of an aldehyde compound by an oxidation reaction of an alcohol compound in the presence of a mesostructured vanadium phosphorus mixed oxide catalyst, at a temperature comprised ...  
WO/2014/122142A1
The present invention concerns a process for the production of an aldehyde compound by an oxidation reaction of an alcohol compound in the presence of a mesostructured vanadium phosphorus mixed oxide catalyst, at a temperature comprised ...  
WO/2014/124358A1
The resin composition comprises pellets having a diameter of less than about 1 mm, for example, 0.75 ± 0.24 mm, and a length/ diameter (UD) ratio of from 0.5 to 2.0. It is further provided a method for manufacturing such a micropelletiz...  
WO/2014/122319A1
The present invention concerns a method for preparing 2,5-furandicarboxylic acid (FDCA) by oxidising 5-hydroxymethylfurfural (HMF) in water in the presence of a weak base and a supported catalyst comprising platinum and bismuth, in which...  
WO/2014/123369A1
The present specification relates to an organic electronic element having an organic material layer containing a novel compound which is capable of improving the lifespan, efficiency, electrochemical stability, and thermal stability of t...  
WO/2014/121633A1
Disclosed are a derivative of homoserine lactone shown in formula I, and a preparation method and use thereof. The compound has a function of sensing and regulating a bacterial colony, and can be used for prevention and/or treatment of r...  
WO/2014/118556A3
Sphingosine 1-phosphate (S1P) is involved in hyper-proliferative diseases, such as cancer and vascular remodeling in pulmonary arterial hypertension. Inhibitors of sphingosine kinase 1 and 2 (SK1 and SK2), which catalyze the synthesis of...  
WO/2014/120790A1
Methods and compositions of this invention relate to suppressing Ca2+-Release-Activated- Ca2+ (CRAC) channel activity using novel compounds of Formula (I): Compounds of formula (I) have been shown to modulate calcium transport through th...  
WO/2014/118046A1
The invention relates to a method for the carbonylation of olefins, in which at least one olefin is converted with the addition of H2 and CO in the presence of a catalytic system consisting of a ruthenium complex and at least one ligand,...  
WO/2014/118806A9
The present patent discloses a one step process for the synthesis of THF and related ring hydrogenated products form furfural using Palladium metal based carbon supported catalyst with high selectivity and 100% conversion in both batch a...  
WO/2014/119892A1
The present disclosure relates to a novel method for preparing an arylnaphthalene lignan compound. In synthesis of arylnaphthalene lignan compounds and derivatives according to the present disclosure, a naphthalene backbone may be constr...  
WO/2014/118120A1
The present invention relates to new compositions, cross-linkable rubber mixtures containing these compositions, processes for their production and their use in automotive applications, as retarder, especially to reduce Mooney viscosity,...  
WO/2014/118806A1
The present patent discloses a one step process for the synthesis of THF and related ring hydrogenated products form furfural using Palladium metal based carbon supported catalyst with high selectivity and 100% conversion in both batch a...  
WO/2014/113700A1
The present disclosure provides nitroxyl donating pharmaceutical compositions comprising N-substituted hydroxylamine derivatives. The compositions are highly efficacious in treating cardiovascular diseases (e.g., heart failure), have a s...  
WO/2014/113407A3
Inhibitors of EYA tyrosine phosphatase having the structure of Formula I are provided herein. The compounds are useful fo the treatment of certain proliferative diseases and cancer.  
WO/2014/112646A1
The present invention addresses the problem of providing a compound having a selective inhibitory activity on LAT-1 that can be expressed in a tumor cell at a high level. The present invention provides: a compound represented by formula ...  
WO/2014/111446A1
The invention relates to a process for the production of 5-formylvaleric acid and adipic acid or esters thereof from an isomeric mixture of pentenoic acid or esters thereof said mixture comprising at least 4-pentenoic acid or esters ther...  
WO/2014/113696A1
The disclosed subject matter provides N-substituted hydroxylamine derivative compounds, pharmaceutical compositions and kits comprising such compounds, and methods of using such compounds or pharmaceutical compositions. In particular, th...  
WO/2014/113407A2
Inhibitors of EYA tyrosine phosphatase are provided herein, as well as pharmaceutical compositions and methods relating thereto.  
WO/2014/113700A9
The present disclosure provides nitroxyl donating pharmaceutical compositions comprising N-substituted hydroxylamine derivatives. The compositions are highly efficacious in treating cardiovascular diseases (e.g., heart failure), have a s...  
WO/2014/111493A1
A method is described for linking carbon-carbon bonds by reacting carbonic acid salts with aryl, heteroaryl or vinyl alkyl sulphonates such as methane sulphonates, releasing carbon dioxide, in the presence of a bimetallic catalyst system...  
WO/2014/108525A1
A novel process for the preparation of a fluorolactone derivative of the formula (I) and of its acylated derivative of formula (V) wherein R1 stands for a hydroxy protecting group is described. The acylated fluorolactones of formula (V),...  
WO/2014/110491A1
Prodrugs of treprostinil are provided which can be used in the treatment of pulmonary hypertension (PH) or pulmonary arterial hypertension (PAH). The structures of the compounds can be adapted to the particular application for a suitable...  
WO/2014/102413A1
The invention relates to a method for producing organic molecules, comprising the following steps: (a) a first step of selective esterification of the hydroxymethyl group of 5-hydroxymethylfurfural (HMF) in the presence of at least one c...  
WO/2014/105289A1
In some variations, the invention provides a process for producing furfural, 5- hydroxymethylfurfural, and/or levulinic acid from cellulosic biomass, comprising: fractionating the feedstock in the presence of a solvent for lignin, sulfur...  
WO/2014/104144A1
Provided are: a fused ring amine compound represented by formula (1) which has a furan ring or a thiophene ring; and an organic electroluminescent element including an organic thin film layer comprising a negative electrode, a positive e...  
WO/2014/104400A1
Provided is an actinic-ray- or radiation-sensitive resin composition including a resin (A) and any of compounds (B) of general formula (I) below. (In general formula (I), Rf represents a fluorine atom or a monovalent organic group contai...  
WO/2014/104513A1
Provided are a high refractive (meta) acrylate derivative and a method for preparing the same, and more particularly, a novel high refractive (meta) acrylate derivative having a high refractive index, capable of being used in a display c...  
WO/2014/101134A1
Provided are a folic acid derivative, a preparing method thereof, and a composition and a kit containing the folic acid derivative. The folic acid derivative is (R)-2-(2-(R)-3,4-dihydroxy-5-carbonyl-2,5-dihydrofuran)-2-hy droxyethyl-4-(6...  
WO/2014/097711A1
This organic electroluminescent element is characterized in being provided with a positive electrode, a negative electrode provided opposing the positive electrode, and an organic layer provided between the positive electrode and the neg...  
WO/2014/096305A1
The present invention relates to a process for preparing MTHF or gamma-butyrolactone, or derivatives thereof, from tricarboxylic acid, from tricarboxylic acid anhydride or from tricarboxylic acid ester, in an alcohol and in the presence ...  
WO/2014/099438A2
A method of making a furan dicarboxylate by means of reacting 2,5-furan dicarboxylic acid (FDCA) with an alcohol or mixture of alcohols in a CO2-predominant atmosphere without the presence of any other acid catalyst is described. The rea...  
WO/2014/097721A1
The ascorbic acid derivative composition according to the first embodiment of the present invention comprises a salt of a compound (1) represented by general formula (1) and a salt of a compound (2) represented by general formula (2), an...  
WO/2014/099408A2
Systems and methods generate steam in hydrocarbon recovery operations and may further enable emulsion separation and product upgrading. The methods rely on indirect boiling of water by contact with a thermal transfer liquid heated to a t...  

Matches 51 - 100 out of 28,400